A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Yohimbine
Robenacoxib
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Robenacoxib.
Yohimbine
Talniflumate
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Talniflumate.
Yohimbine
Propacetamol
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Propacetamol.
Yohimbine
Morniflumate
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Morniflumate.
Yohimbine
Clonixin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Clonixin.
Yohimbine
Firocoxib
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Firocoxib.
Yohimbine
Tolfenamic acid
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Tolfenamic acid.
Yohimbine
Droxicam
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Droxicam.
Yohimbine
Dexketoprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Dexketoprofen.
Yohimbine
Benzydamine
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Benzydamine.
Yohimbine
Epirizole
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Epirizole.
Yohimbine
Etofenamate
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Etofenamate.
Yohimbine
Fenbufen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Fenbufen.
Yohimbine
Floctafenine
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Floctafenine.
Yohimbine
Ibuproxam
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Ibuproxam.
Yohimbine
Indoprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Indoprofen.
Yohimbine
Isoxicam
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Isoxicam.
Yohimbine
Kebuzone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Kebuzone.
Yohimbine
Salicylamide
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Salicylamide.
Yohimbine
Parecoxib
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Parecoxib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3